- US-listed companies
- ABBOTT LABORATORIES
- Balance sheet
ABBOTT LABORATORIES【ABT】Balance sheet
Market cap
$219.2B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 3,648 | 6,813 | 10,802 | 3,475 | 4,063 | 5,001 | 18,620 | 9,407 | 3,844 | 3,860 | 6,838 | 9,799 | 9,882 | 6,896 | 7,616 |
| Marketable securities, current | 1,803 | 1,285 | 4,372 | 4,623 | 397 | 1,124 | 155 | 203 | 242 | 280 | 310 | 450 | 288 | 383 | 351 |
| Total cash & short-term investments | 5,451 | 8,097 | 15,174 | 8,098 | 4,460 | 6,125 | 18,775 | 9,610 | 4,086 | 4,140 | 7,148 | 10,249 | 10,170 | 7,279 | 7,967 |
| Accounts receivable, net | 7,184 | 7,684 | 7,613 | 3,986 | 3,586 | 3,418 | 3,248 | 5,249 | 5,182 | 5,425 | 6,414 | 6,487 | 6,218 | 6,565 | 6,925 |
| Inventories | 3,189 | 3,284 | 3,792 | 2,693 | 2,643 | 2,599 | 2,434 | 3,601 | 3,796 | 4,316 | 5,012 | 5,157 | 6,173 | 6,570 | 6,194 |
| Total current assets | 22,318 | 23,769 | 31,323 | 19,247 | 15,261 | 14,155 | 26,776 | 20,147 | 14,632 | 15,667 | 20,441 | 24,239 | 25,224 | 22,670 | 23,656 |
| Property, plant and equipment, net | 7,971 | 7,874 | 8,063 | 5,905 | 5,935 | 5,730 | 5,705 | 7,607 | 7,563 | 8,038 | 9,029 | 8,959 | 9,162 | 10,154 | 10,658 |
| Marketable securities, non-current | 302 | 378 | 274 | 119 | 229 | 4,041 | 2,947 | 883 | 897 | 883 | 821 | 816 | 766 | 799 | 886 |
| Total non-current assets | 37,145 | 36,508 | 35,912 | 23,706 | 26,014 | 27,092 | 25,890 | 56,103 | 52,541 | 52,220 | 52,107 | 50,957 | 49,214 | 50,544 | 57,758 |
| Total assets | 59,462 | 60,277 | 67,235 | 42,953 | 41,275 | 41,247 | 52,666 | 76,250 | 67,173 | 67,887 | 72,548 | 75,196 | 74,438 | 73,214 | 81,414 |
| Long-term debt, current | 2,045 | 1,027 | 309 | 9 | 55 | 3 | 3 | 508 | 7 | 1,277 | 7 | 754 | 2,251 | 1,080 | 1,500 |
| Total current liabilities | 17,262 | 15,480 | 13,280 | 9,507 | 10,532 | 9,186 | 6,660 | 8,912 | 9,012 | 10,863 | 11,907 | 13,105 | 15,489 | 13,841 | 14,157 |
| Long-term debt, non-current | 12,524 | 12,040 | 18,085 | 3,388 | 3,408 | 5,871 | 20,681 | 27,210 | 19,359 | 16,661 | 18,527 | 17,296 | 14,522 | 13,599 | 12,625 |
| Common stock and paid-in capital | 8,745 | - | - | 12,048 | 12,383 | 12,734 | 13,027 | 23,206 | 23,512 | 23,853 | 24,145 | 24,470 | 24,709 | 24,869 | 25,153 |
| Retained earnings | 18,927 | 20,907 | 24,151 | 21,979 | 22,874 | 25,757 | 25,565 | 23,978 | 24,560 | 25,847 | 27,627 | 31,528 | 35,257 | 37,554 | 47,261 |
| Stockholders' equity | 22,476 | 24,526 | 26,813 | 25,267 | 21,639 | 21,326 | 20,717 | 31,098 | 30,722 | 31,301 | 33,003 | 36,024 | 36,905 | 38,827 | 47,901 |
| Total debt | 14,568 | 13,067 | 18,394 | 3,397 | 3,448 | 5,874 | 20,684 | 27,718 | 19,366 | 17,938 | 18,534 | 18,050 | 16,773 | 14,679 | 14,125 |
| Net debt | 9,117 | 4,969 | 3,220 | -4,701 | -1,012 | -251 | 1,909 | 18,108 | 15,280 | 13,798 | 11,386 | 7,801 | 6,603 | 7,400 | 6,158 |
| D/E ratio (%) | 64.8 | 53.3 | 68.6 | 13.4 | 15.9 | 27.5 | 99.8 | 89.1 | 63 | 57.3 | 56.2 | 50.1 | 45.4 | 37.8 | 29.5 |